Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anamorelin for Cancer Cachexia
NCT01505764Phase 2Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anamorelin in cancer cachexia, sponsored by VA Office of Research & Development. Started Jun 2012; status: terminated.
02
Drugs
anamorelin
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT01505764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01505764.